Uy Ear

Stock Analyst at Mizuho

(3.94)
# 635
Out of 5,043 analysts
70
Total ratings
48.78%
Success rate
13.71%
Average return

Stocks Rated by Uy Ear

Alkermes
Oct 27, 2025
Maintains: Outperform
Price Target: $40$45
Current: $29.72
Upside: +51.41%
uniQure
Sep 25, 2025
Maintains: Outperform
Price Target: $30$60
Current: $67.92
Upside: -11.66%
MBX Biosciences
Sep 24, 2025
Maintains: Outperform
Price Target: $38$56
Current: $17.44
Upside: +221.10%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Neutral
Price Target: $23$24
Current: $22.99
Upside: +4.39%
Sarepta Therapeutics
Jul 21, 2025
Downgrades: Neutral
Price Target: $40$14
Current: $23.50
Upside: -40.43%
Tectonic Therapeutic
May 15, 2025
Maintains: Outperform
Price Target: $51$85
Current: $18.62
Upside: +356.50%
Arcutis Biotherapeutics
Feb 26, 2025
Maintains: Outperform
Price Target: $20$21
Current: $19.64
Upside: +6.92%
Relmada Therapeutics
Dec 5, 2024
Downgrades: Neutral
Price Target: $23$1
Current: $2.33
Upside: -57.08%
Cartesian Therapeutics
May 24, 2024
Initiates: Buy
Price Target: $40
Current: $8.85
Upside: +351.98%
Evolus
Mar 8, 2024
Maintains: Buy
Price Target: $20$23
Current: $7.22
Upside: +218.56%
Maintains: Neutral
Price Target: $116$140
Current: $148.94
Upside: -6.00%
Maintains: Buy
Price Target: $36$40
Current: $190.30
Upside: -78.98%
Reiterates: Buy
Price Target: $10
Current: $2.79
Upside: +258.42%
Maintains: Buy
Price Target: $5$3
Current: $1.56
Upside: +92.31%